TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment. March 31, 2000
TCL Archive In Brief: WHO Begins Project To Urge Governments To Establish “National Cancer Programs” October 30, 1998
TCL Archive Pao Named Director of Department Of Hematology And Oncology At Vanderbilt University September 30, 2011
TCL Archive In Brief: Former ICCCR Staff Form International Marketing Firm; M.D. Andersons Names New Professorship October 2, 1992
TCL Archive Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards July 31, 2009
